回复了评论 2024-01-23

RECENT PAT ANTI-CANC

审稿流程说一下,大佬

回复了评论 2023-12-25

IMMUNOTHERAPY-UK

in peer review快4个月,好慢

回复了评论 2023-12-18

IMMUNOTHERAPY-UK

投稿3个多月,还在in peer review

回复了评论 2023-09-20

TRANSL ONCOL

拒稿了

回复了评论 2023-04-13

TRANSL ONCOL

凉了

回复了评论 2023-03-18

CRIT REV ONCOL HEMAT

拒稿了

回复了评论 2023-03-18

TRANSL ONCOL

我也是这样

回复了评论 2023-03-10

CRIT REV ONCOL HEMAT

with editor 多久送审啊

回复了评论 2022-11-28

TRANSPL CELL THER

是不是SCI?

回复了评论 2021-11-06

BLOOD

Thank you very much for sending your manuscript, referenced above, to Blood. Your paper was carefully reviewed at the editorial level; and while we agree that your work is interesting, we regret to inform you that we will be unable to consider it for publication. The journal does not generally publish single clinical case reports. Because of high submission rates, Blood can publish only a fraction of the papers received. As a result, a priority system for publication has been established, based not only on quality of the work, but also on relevance to hematology; the definitive and novel nature of the findings reported; and other factors, both intrinsic and relative to other papers submitted to Blood for consideration. We recognize that many good papers are not selected for publication in Blood. We hope that our expedited editorial decision will allow you to submit your work to another journal with minimal delay. We greatly appreciate your interest in publishing in Blood. Sincerely

回复了评论 2021-11-06

BLOOD

不收

回复了评论 2020-12-24

FRONT ONCOL

就在那个投稿里面,登陆进去就可以交

回复了评论 2020-12-22

FRONT ONCOL

嗯嗯

回复了评论 2020-09-16

FRONTIERS IN ONCOLOGY

我也是一个审稿人同意,一个退出,现在都快2个月了,一点消息也没有,发邮件也没人回复

回复了评论 2020-08-12

FRONT ONCOL

应该快接受了

共27条页码: 1/2页15条/页